Sunday, April 22, 2018
Health

New drug shows promise as migraine headache preventive

Reporters and editors get dozens of emails and story pitches every day. But one recent news release from the American Academy of Neurology caught my attention immediately.

It was about a clinical trial involving a new drug for preventing migraine headaches. Even better, it's part of a new class of drugs specifically developed to prevent migraines. All the preventive medications currently available were first used to treat other health conditions.

In the new trial, patients reported fewer headache days each month, with almost no major side effects.

It was the best news to come along in years. Suddenly I was hopeful about getting relief from a painful condition that has dogged me for more than three decades.

My migraines started when I was in elementary school in Virginia. I used to call them a headache in my eye. Maybe that's why my parents kept taking me to opticians and buying me eyeglasses with sparkly pink frames and stars and poodles on the sides — they thought the headaches were caused by eye strain.

The glasses didn't help. But because the headaches were isolated and occurred just a few times a year, we didn't give them much thought. I don't remember taking so much as an aspirin for the pain or being taken to the doctor because of them.

It wasn't until I landed a new job and moved to Florida in 1985 that the headaches became much more frequent and debilitating. It took a while for me to eventually connect with a neurologist who told me I had migraines. By this time, I rarely woke without a headache.

I also noticed they could be triggered by hunger, alcohol, caffeine, citrus or changes in my sleep schedule.

My mistake was trying to manage the problem myself and not seeking treatment with a specialist sooner. I thought I just had headaches more often than other people — that the only thing to do was to take Tylenol. And when that didn't work, to just take more.

Eventually, I learned that taking too much pain medication made the pills less effective and caused even more headaches, known as rebound headaches. And, I learned that most people who have frequent migraines need to be on a daily preventive medication to reduce the need for pain relievers.

A daily preventive isn't something you take after a headache hits. It's taken every day, even on days without headaches, to prevent the attacks, lessen their number and to reduce the pain intensity of those that do break through.

According to the National Headache Foundation, migraines affect more than 30 million Americans, more women than men. About 3 million suffer chronic migraines — meaning a headache 15 or more days each month for three months or more, with eight of them being migranic in nature, lasting four or more hours.

As a chronic migraine headache sufferer, you're also most likely missing a lot of work or school or social activities, and are unable to perform some activities of daily living like grocery shopping, housekeeping, working out or shuttling children around.

"Preventives increase the number of days that you can work, socialize, participate in life," said Dr. Teshamae Monteith, a headache neurologist and chief of the headache division in the department of neurology at the University of Miami Miller School of Medicine. "Preventives can reduce the frequency and severity of attacks, make treatments, even over-the-counter ones, work better and generally make migraines easier to treat."

The most common preventives were originally intended to treat such health problems as high blood pressure, depression, epilepsy, even aging. They often come with bothersome, sometimes intolerable, side effects, including dry mouth, drowsiness, weight gain, constipation, mind fog, difficulty speaking or swallowing, changes in taste, tremors, nightmares and hallucinations.

I've had to abandon several preventives because of side effects. Others worked for a while and then, after a few years, stopped working.

Some patients find relief from a common cosmetic procedure.

"I have a lot of success treating patients with Botox. It's helpful for a good percentage of people," said Dr. Robert Vollbracht, a headache neurologist at Clinical Neurosciences of Tampa Bay based at Morton Plant Hospital in Clearwater.

Botox is best known for smoothing wrinkles and relaxing the "parenthesis" frown lines between the eyebrows. To treat chronic migraines, patients receive 31 injections of botulinum toxin around the head and neck. The injections are given every 12 weeks; it can take two or three rounds of treatment to get results.

Some patients find the shots painful but report getting relief for several months at a time. (Vollbracht says diluting the medication slightly can make the injections less painful.)

Doctors aren't sure why Botox works, but they think it does more than just relax the head and neck muscles. It may play a role in preventing the body from sending out pain signals during headaches. Still, it is the only FDA-approved drug for prevention of chronic migraines.

"I find that preventives work about 50 percent of the time. So it can take a lot of trial and error to find one that works for you," Vollbracht said. "It may take a combination of medications to get results." Or sometimes the dose just needs to be adjusted.

Patients need to understand, he added, that what doesn't work for you may work for someone else. You also have to give the medications time. It can take weeks or months to get relief.

The new medication that got my attention doesn't even have a name yet. It's known as TEV-48125 and is a monoclonal antibody, part of a new class of drugs that target and block a chemical in the brain called CGRP that increases during migraine headaches. TEV-48125 is manufactured by Teva Pharmaceuticals, and three similar drugs are currently in development.

In a study released earlier this month by Teva, some patients with chronic migraines reported relief within days of the first treatment. After a week, people on a low dose of the drug had an average of nine fewer hours of head pain, and those on a higher dose had 11 fewer headache hours. In the trial, reported in the journal Neurology, the drug was injected once a month for three months.

"This one from Teva is quite exciting," said Dr. Janice Maldonado, an assistant professor of neurology at USF Health based at the Neurology, Pain and Headache Clinic at Tampa General Hospital. She is not involved in the clinical trial.

"This takes into consideration the physiology of migraine," Maldonado said. "It's a carefully thought out approach to treatment that attacks the generator of the migraine itself. It should work."

Monteith, the Miami neurologist, is part of a clinical trial testing a similar monoclonal antibody manufactured by Eli Lilly and Co. for the treatment of cluster headaches. She thinks TEV-48125 looks promising too.

"It treats the root cause of migraines," she said. "It may also be safe for people with cardiovascular disease, but further study is needed to confirm that. That might be a bonus."

One of the key classes of drugs for stopping a migraine after it starts, the triptans, (Sumatriptan or Imitrex, Eletriptan or Relpax and Zolmitriptan or Zomig) can't be given to people with certain heart conditions or a heart attack or stroke history because of the effect they have on blood vessels.

The clinical trials continue, but doctors are hopeful the FDA could approve the first CGRP blocker by 2018.

What will it cost? It's hard to say, but some experts estimate the drug will run between $8,000 and $20,000 a year. Some monoclonal antibodies currently used to treat cancer, for example, cost as much as $50,000 annually. Getting insurance companies to cover such expensive drugs may be difficult and will take time. Copays could be high.

Scientists also need to know what the long-term health effects of using a CGRP blocker are and how the drug will perform when given to thousands of patients in large nationwide trials, instead of a few hundred patients at a handful of study sites.

Still, I can't help but be quietly excited. And, hopeful for the first time in years.

Times researcher John Martin contributed to this report. Contact Irene Maher at [email protected]

   
Comments
Do not eat any romaine lettuce, the CDC warns

Do not eat any romaine lettuce, the CDC warns

Public health officials are now telling consumers to avoid all types of romaine lettuce because of an E. coli outbreak linked to the vegetable that has spread to at least 16 states and sickened at least 60 people, including eight inmates at an Alask...
Published: 04/20/18
Florida hits a milestone: More than 100,000 people are registered to use medical marijuana here

Florida hits a milestone: More than 100,000 people are registered to use medical marijuana here

Florida has hit a milestone of sorts as it slowly moves toward wider availability of medical marijuana.The number of patients in the state who are registered to use the substance has surpassed 100,000 for the first time, according to Florida Departme...
Published: 04/20/18
Florida Hospital Carrollwood spending $17.5 million to expand emergency department

Florida Hospital Carrollwood spending $17.5 million to expand emergency department

Florida Hospital Carrollwood is expanding its emergency department. The hospital, 7171 North Dale Mabry Highway in Tampa, is spending $17.5 million to add 15 new private treatment rooms, new pediatric rooms and waiting areas, and new technology, acco...
Published: 04/18/18
Barbara Bush’s end-of-life decision stirs debate over ‘comfort care’

Barbara Bush’s end-of-life decision stirs debate over ‘comfort care’

As she nears death at age 92, former first lady Barbara Bush’s announcement that she is seeking "comfort care" is shining a light — and stirring debate — on what it means to stop trying to fight terminal illness.Bush, the wife of former President Geo...
Published: 04/17/18
Preparing for the worst, staffers at Johns Hopkins All Children’s learn through simulation

Preparing for the worst, staffers at Johns Hopkins All Children’s learn through simulation

When the patient got violent, Dr. Michelle Hidalgo didn’t have time to think. She had to react. The woman was moving strangely and seemed erratic. Hidalgo had to make a tough call — it was time to physically restrain her for everyone’s safety.Then th...
Published: 04/16/18
Updated: 04/17/18

Lung cancer patients live longer with immune therapy

The odds of survival can greatly improve for people with the most common type of lung cancer if, along with the usual chemotherapy, they are also given a drug that activates the immune system, a major new study has shown.The findings should change me...
Published: 04/16/18
Thousands of pounds of prepackaged salad mixes may have been tainted with E. coli, officials say

Thousands of pounds of prepackaged salad mixes may have been tainted with E. coli, officials say

A Pennsylvania food manufacturer is recalling 8, 757 pounds of ready-to-eat salad products following an E. coli outbreak that has spread to several states and sickened dozens of people.Fresh food Manufacturing Co., based in Freedom, Pennsylvania, is ...
Published: 04/15/18
St. Anthony’s Cancer Center installs bell dedicated to survivors

St. Anthony’s Cancer Center installs bell dedicated to survivors

ST. PETERSBURGSister Mary McNally, vice president of mission at St. Anthony’s Hospital, stood in front of a room of cancer survivors to unveil a silver bell surrounded by butterfly stickers mounted to the wall of the Cancer Center lobby. "So often pe...
Published: 04/13/18
Hand dryers could leave your hands dirtier than you think

Hand dryers could leave your hands dirtier than you think

Washing your hands after you use the bathroom is a good idea. But using a public dryer could undo all that hard work, according to a new study.A study, published in the journal Applied and Environmental Microbiology, examined 36 men’s and women’s bat...
Published: 04/13/18
Meek and Mighty Triathlon draws the young (siblings who are 7, 9 and 11) and not so young

Meek and Mighty Triathlon draws the young (siblings who are 7, 9 and 11) and not so young

The annual St. Anthony’s Triathlon has for years attracted elite athletes from around the world, making the St. Petersburg race one of the premier triathlon events in the country. There’s a big incentive to run fast, swim hard and be the best on a bi...
Published: 04/13/18